These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 5973714)

  • 21. [Efficiency of the clinical use of short-term controlled treatment (DOTS) in patients with new-onset destructive pulmonary tuberculosis].
    Petrenko VM; Litvinenko NA
    Probl Tuberk Bolezn Legk; 2005; (3):16-20. PubMed ID: 15945446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Time to culture conversion in smokers with pulmonary tuberculosis.
    Gullón JA; Suárez I; Lecuona M; Fernández R; Rubinos G; Medina A; Cabrera C; González I
    Monaldi Arch Chest Dis; 2009 Sep; 71(3):127-31. PubMed ID: 19999959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The action of blood ozonization on the course of progressive pulmonary tuberculosis combined with diabetes mellitus].
    Belianin II
    Ter Arkh; 1997; 69(11):44-8. PubMed ID: 9483747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of previous tuberculosis treatment history on acid-fast bacilli smear and culture conversion.
    Lee J; Lee BJ; Yoon HI; Lee CT; Lee JH
    Int J Tuberc Lung Dis; 2012 Oct; 16(10):1344-8. PubMed ID: 23107634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical significance of casual isolation of acid-fast organisms from sputum of tuberculous patients.
    Tsukamura M
    Am Rev Respir Dis; 1973 Dec; 108(6):1429-30. PubMed ID: 4201631
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical significance of Mycobacterium tuberculosis polydrug resistance in chronic destructive forms of pulmonary tuberculosis].
    Bialik IB; Klimenko MT
    Probl Tuberk; 1980 Oct; (10):68-70. PubMed ID: 6776517
    [No Abstract]   [Full Text] [Related]  

  • 27. [Changes in the bacteriological findings in caverns treated locally with "Rifomycin B diethylamide" during intracavitary aspiration].
    Masone S; Meola G
    Arch Tisiol Mal Appar Respir; 1966 Nov; 21(11):923-9. PubMed ID: 4969275
    [No Abstract]   [Full Text] [Related]  

  • 28. [Incidence and clinical significance of visible but not viable bacilli in patients with pulmonary tuberculosis].
    Krychniak W; Araszkiewicz W; Zych D; Janowiec M; Pelczarska B
    Gruzlica; 1975 Sep; 43(9):785-92. PubMed ID: 808444
    [No Abstract]   [Full Text] [Related]  

  • 29. Acid-fast bacilli in sputum smears of patients with pulmonary tuberculosis. Prevalence and significance of negative smears pretreatment and positive smears post-treatment.
    Kim TC; Blackman RS; Heatwole KM; Kim T; Rochester DF
    Am Rev Respir Dis; 1984 Feb; 129(2):264-8. PubMed ID: 6421211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sputum monitoring during tuberculosis treatment for predicting outcome.
    Humbwavali JB; Trujillo NJ; Paim BS; Wolff FH; Barcellos NT
    Lancet Infect Dis; 2011 Mar; 11(3):160; author reply 160-1. PubMed ID: 21371650
    [No Abstract]   [Full Text] [Related]  

  • 31. [The significance of persistent cavities after achieved sputum conversion].
    Eule ; Ewert
    Z Tuberk Erkr Thoraxorg; 1966; 125(3):168-71. PubMed ID: 6014517
    [No Abstract]   [Full Text] [Related]  

  • 32. Relationship between sputum smear grading and smear conversion rate and treatment outcome in the patients of pulmonary tuberculosis undergoing dots--a prospective cohort study.
    Tiwari S; Kumar A; Kapoor SK
    Indian J Tuberc; 2012 Jul; 59(3):135-40. PubMed ID: 23362709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of pulmonary tuberculosis in a low-prevalence urban area. Compliance and sputum conversion].
    Stoffel C; Lorenz R; Arce M; Rico M; Fernández L; Imaz MS
    Medicina (B Aires); 2014; 74(1):9-18. PubMed ID: 24561834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Healing of the lung caverns based on data from bacteriological and morphological studies].
    Vorozhtsova MP
    Probl Tuberk; 1988; (1):35-7. PubMed ID: 3129714
    [No Abstract]   [Full Text] [Related]  

  • 35. Association between Mycobacterium tuberculosis lineage and time to sputum culture conversion.
    Click ES; Winston CA; Oeltmann JE; Moonan PK; Mac Kenzie WR
    Int J Tuberc Lung Dis; 2013 Jul; 17(7):878-84. PubMed ID: 23743308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The relation between bacilli negative conversion rate and the number of combined sensitive antituberculous drugs in intermittent administration of rifampicin for severe pulmonary tuberculosis].
    Tamura M; Yamazaki A; Tamura T; Takano S; Yamazaki M
    Kekkaku; 1973 Jul; 48(7):297-302. PubMed ID: 4200058
    [No Abstract]   [Full Text] [Related]  

  • 37. [Conversion of the sputum--only a relative success measurement in the treatment of tuberculosis. Bacteriological study of 614 resection preparations].
    Winter G; Viereck HJ
    Med Welt; 1972 Sep; 23(38):1294-7. PubMed ID: 5078662
    [No Abstract]   [Full Text] [Related]  

  • 38. Registration and treatment of patients with smear-positive pulmonary tuberculosis.
    Nyirenda T; Harries AD; Banerjee A; Salaniponi FM
    Int J Tuberc Lung Dis; 1998 Nov; 2(11):944-5. PubMed ID: 9848620
    [No Abstract]   [Full Text] [Related]  

  • 39. [In 76% of patients with active tuberculosis treated with triple therapy (isoniazid-rifampicin-pyrazinamide) cultural conversion precedes microscopic conversion].
    Nowak D; Radenbach D; Magnussen H
    Pneumologie; 1990 Feb; 44 Suppl 1():497-8. PubMed ID: 2114634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early stationary phase culture supernatant accelerates growth of sputum cultures collected after initiation of anti-tuberculosis treatment.
    Kolwijck E; Friedrich SO; Karinja MN; van Ingen J; Warren RM; Diacon AH
    Clin Microbiol Infect; 2014 Jul; 20(7):O418-20. PubMed ID: 24188165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.